B. Riley Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.46M | Sell |
2,883
-71
| -2% | -$34.1K | 0.08% | 225 |
|
|
2026
Q1 | $1.42M | Sell |
2,954
-1,690
| -36% | -$917K | 0.09% | 217 |
|
|
2025
Q4 | $2.69M | Sell |
4,644
-147
| -3% | -$83.1K | 0.12% | 167 |
|
|
2025
Q3 | $2.32M | Sell |
4,791
-856
| -15% | -$398K | 0.11% | 183 |
|
|
2025
Q2 | $2.29M | Buy |
+5,647
| New | +$2.36M | 0.11% | 187 |
|
|
2024
Q4 | $9.17M | Sell |
17,618
-1,547
| -8% | -$851K | 0.3% | 65 |
|
|
2024
Q3 | $11.7M | Sell |
19,165
-2,647
| -12% | -$1.57M | 0.32% | 62 |
|
|
2024
Q2 | $12.1M | Sell |
21,812
-8,144
| -27% | -$4.67M | 0.31% | 63 |
|
|
2024
Q1 | $15.2M | Buy |
29,956
+2,586
| +9% | +$1.45M | 0.41% | 45 |
|
|
2023
Q4 | $14.5M | Sell |
27,370
-2,586
| -9% | -$1.25M | 0.39% | 45 |
|
|
2023
Q3 | $15.2M | Sell |
29,956
-1,175
| -4% | -$626K | 0.41% | 45 |
|
|
2023
Q2 | $16.3M | Sell |
31,131
-2,328
| -7% | -$1.26M | 0.36% | 54 |
|
|
2023
Q1 | $19.3M | Sell |
33,459
-5,738
| -15% | -$3.23M | 0.51% | 35 |
|
|
2022
Q4 | $21.6M | Sell |
39,197
-1,515
| -4% | -$803K | 0.61% | 25 |
|
|
2022
Q3 | $20.6M | Buy |
40,712
+18,716
| +85% | +$10.5M | 0.62% | 25 |
|
|
2022
Q2 | $11.9M | Sell |
21,996
-470
| -2% | -$259K | 0.5% | 38 |
|
|
2022
Q1 | $13.3M | Buy |
22,466
+395
| +2% | +$227K | 0.43% | 43 |
|
|
2021
Q4 | $14.7M | Buy |
22,071
+739
| +3% | +$461K | 0.42% | 42 |
|
|
2021
Q3 | $12.1M | Buy |
21,332
+898
| +4% | +$493K | 0.38% | 53 |
|
|
2021
Q2 | $10.3M | Buy |
20,434
+3,778
| +23% | +$1.78M | 0.33% | 62 |
|
|
2021
Q1 | $7.61M | Buy |
16,656
+7,139
| +75% | +$3.41M | 0.27% | 80 |
|
|
2020
Q4 | $4.43M | Sell |
9,517
-2,666
| -22% | -$1.25M | 0.24% | 98 |
|
|
2020
Q3 | $5.08M | Buy |
12,183
+3,621
| +42% | +$1.5M | 0.27% | 87 |
|
|
2020
Q2 | $3.1M | Buy |
8,562
+224
| +3% | +$75.1K | 0.21% | 119 |
|
|
2020
Q1 | $2.37M | Buy |
8,338
+4,169
| +100% | +$1.31M | 0.2% | 119 |
|
|
2019
Q4 | $1.35M | Buy |
4,169
+266
| +7% | +$80.7K | 0.12% | 199 |
|
|
2019
Q3 | $1.14M | Sell |
3,903
-827
| -17% | -$237K | 0.11% | 202 |
|
|
2019
Q2 | $1.39M | Buy |
4,730
+1,098
| +30% | +$302K | 0.15% | 142 |
|
|
2019
Q1 | $996K | Buy |
3,632
+180
| +5% | +$44.8K | 0.12% | 186 |
|
|
2018
Q4 | $774K | Sell |
3,452
-310
| -8% | -$72.7K | 0.11% | 201 |
|
|
2018
Q3 | $920K | Buy |
3,762
+89
| +2% | +$20.5K | 0.11% | 204 |
|
|
2018
Q2 | $763K | Buy |
3,673
+174
| +5% | +$36.9K | 0.1% | 218 |
|
|
2018
Q1 | $724K | Buy |
3,499
+285
| +9% | +$59.8K | 0.1% | 218 |
|
|
2017
Q4 | $612K | Buy |
3,214
+81
| +3% | +$15.5K | 0.08% | 263 |
|
|
2017
Q3 | $595K | Buy |
3,133
+47
| +2% | +$8.51K | 0.1% | 226 |
|
|
2017
Q2 | $540K | Buy |
3,086
+181
| +6% | +$30.4K | 0.1% | 239 |
|
|
2017
Q1 | $447K | Buy |
2,905
+172
| +6% | +$26.3K | 0.09% | 255 |
|
|
2016
Q4 | $386K | Sell |
2,733
-210
| -7% | -$31K | 0.08% | 287 |
|
|
2016
Q3 | $469K | Buy |
2,943
+48
| +2% | +$7.4K | 0.09% | 280 |
|
|
2016
Q2 | $429K | Sell |
2,895
-320
| -10% | -$47.2K | 0.09% | 287 |
|
|
2016
Q1 | $455K | Buy |
3,215
+28
| +0.9% | +$3.75K | 0.11% | 242 |
|
|
2015
Q4 | $453K | Sell |
3,187
-15
| -0.5% | -$2K | 0.09% | 271 |
|
|
2015
Q3 | $392K | Buy |
3,202
+247
| +8% | +$32.2K | 0.09% | 277 |
|
|
2015
Q2 | $385K | Buy |
2,955
+608
| +26% | +$79.3K | 0.1% | 265 |
|
|
2015
Q1 | $316K | Buy |
2,347
+168
| +8% | +$21.7K | 0.08% | 336 |
|
|
2014
Q4 | $273 | Buy |
2,179
+17
| +0.8% | +$2.07K | 0.01% | 1172 |
|
|
2014
Q3 | $263K | Sell |
2,162
-2,197
| -50% | -$267K | 0.07% | 408 |
|
|
2014
Q2 | $282K | Buy |
4,359
+2,384
| +121% | +$281K | 0.07% | 332 |
|
|
2014
Q1 | $237K | Buy |
+1,975
| New | +$235K | 0.07% | 325 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
B. Riley Wealth Advisors's TMO Position: Q2 2026 in Review
B. Riley Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, selling an estimated $34.1K and leaving 2,883 shares worth $1.46M. The position accounts for 0.08% of the portfolio, ranked #225.
B. Riley Wealth Advisors first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $21.6M in Q4 2022. 875 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- B. Riley Wealth Advisors held 2,883 shares of Thermo Fisher Scientific worth $1.46M as of Q2 2026.
- B. Riley Wealth Advisors sold 71 Thermo Fisher Scientific shares in Q2 2026, an estimated $34.1K.
- Thermo Fisher Scientific made up 0.08% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #225 holding.
- B. Riley Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
- B. Riley Wealth Advisors's Thermo Fisher Scientific position peaked at $21.6M in Q4 2022.
- 875 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.